In what Vertex Pharmaceuticals is calling a planned succession, Jeffrey Leiden will replace Matthew Emmens as CEO on Feb. 1. The front-office shuffle comes as the Cambridge-based company — now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback